---
title: "Descartes-08 in Generalized myasthenia gravis: Economic impact of diagnostic testing"
description: "Formulary evidence on Descartes-08 in Generalized myasthenia gravis: Economic impact of diagnostic testing. Topics: Out-of-pocket cost of receiving a diagnosis reported by U.S. patients; Medicaid payment rates for acetylcholine receptor and MuSK antibody tests: Massachusetts, January 2024. 2 evidence topics quoted from 2 sources."
canonical: "https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/product-information-and-disease-description/economic-impact-of-diagnostic-testing"
published: "2026-11-19T12:09:07-05:00"
modified: "2026-11-19T12:09:07-05:00"
---

# Descartes-08 in Generalized myasthenia gravis: Economic impact of diagnostic testing

<a id="heading-2.2.1.8.4"></a>

## 2.2.1.8.4 Economic Impact of Diagnostic Testing

<a id="topic-2.2.1.8.4-1"></a>

### Out-of-pocket cost of receiving a diagnosis reported by U.S. patients

> “Demographic disparities were observed, with people of color, women, and those on disability paying significantly more to receive a diagnosis than their counterparts.”

Source: [Yoder et al. (2025)](https://pubmed.ncbi.nlm.nih.gov/39697037/)

<a id="topic-2.2.1.8.4-2"></a>

### Medicaid payment rates for acetylcholine receptor and MuSK antibody tests: Massachusetts, January 2024

> “In accordance with 101 CMR 320.01(4)(c), the Executive Office of Health and Human Services (EOHHS) is adding new service codes effective for dates of service on and after January 1, 2024.”

Source: [Massachusetts Executive Office of Health and Human Services Administrative Bulletin 24-19 (2024)](https://www.mass.gov/doc/administrative-bulletin-24-19-101-cmr-32000-clinical-laboratory-services-2024-cpt-code-updates-effective-january-1-2024-0/download)

| Test | Code | Rate |
| --- | --- | --- |
| “Acetylcholine receptor (AChR); binding antibody” | “86041” | “$16.23” |
| “Acetylcholine receptor (AChR); blocking antibody” | “86042” | “$16.23” |
| “Acetylcholine receptor (AChR); modulating antibody” | “86043” | “$10.63” |
| “Muscle-specific kinase (MuSK) antibody” | “86366” | “$16.23” |

Source: [Massachusetts Executive Office of Health and Human Services Administrative Bulletin 24-19 (2024)](https://www.mass.gov/doc/administrative-bulletin-24-19-101-cmr-32000-clinical-laboratory-services-2024-cpt-code-updates-effective-january-1-2024-0/download)

## Related pages
- [Descartes-08: Generalized myasthenia gravis](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis) · [Markdown](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis.md)
- [Descartes-08 in Generalized myasthenia gravis: Terms and abbreviations](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/terms-and-abbreviations) · [Markdown](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/terms-and-abbreviations.md)
- [Descartes-08: Generalized myasthenia gravis](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/executive-summary) · [Markdown](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/executive-summary.md)
- [Descartes-08 in Generalized myasthenia gravis: Product information and disease description](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/product-information-and-disease-description) · [Markdown](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/product-information-and-disease-description.md)
- [Descartes-08 in Generalized myasthenia gravis: Clinical evidence](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/clinical-evidence) · [Markdown](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/clinical-evidence.md)
- [Descartes-08 in Generalized myasthenia gravis: Economic information and modeling report](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/economics) · [Markdown](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/economics.md)
- [Descartes-08 in Generalized myasthenia gravis: References](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/references) · [Markdown](https://www.evicenter.com/drugs/descartes-08--generalized-myasthenia-gravis/references.md)
